Target Development towards First Production of High-Molar- Activity 44gSc and 47Sc by Mass Separation at CERN-MEDICIS.
Mamis E, Duchemin C, Berlin V, Bernerd C, Bovigny M, Chevallay E, Crepieux B, Gadelshin VM, Heinke R, Hernandez RM, Johnson JD, Kalniņa P, Koliatos A, Lambert L, Rossel RE, Rothe S, Thiboud J, Weber F, Wendt K, Zabolockis RJ, Pajuste E, Stora T.
Mamis E, et al. Among authors: hernandez rm.
Pharmaceuticals (Basel). 2024 Mar 18;17(3):390. doi: 10.3390/ph17030390.
Pharmaceuticals (Basel). 2024.
PMID: 38543176